The glitazones: proceed with caution.
Krische
D
D
University of Washington, Seattle, WA 98195-6015, USA. dkrische@u.washington.edu
D002839:Chromans / Q000627:therapeutic use*; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D004341:Drug Evaluation; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D008099:Liver / Q000187:drug effects; D000077205:Pioglitazone; D011379:Prognosis; D000077154:Rosiglitazone; D012449:Safety; D013844:Thiazoles / Q000627:therapeutic use*; D045162:Thiazolidinediones; D000077288:Troglitazone; D015430:Weight Gain / Q000187:drug effects
D002839:Chromans; D007004:Hypoglycemic Agents; D013844:Thiazoles; D045162:Thiazolidinediones; D000077154:Rosiglitazone; D000077288:Troglitazone; D000077205:Pioglitazone